Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,023,950 papers from all fields of science
Search
Sign In
Create Free Account
2-chlorobenzenesulfonyl chloride
Known as:
2-CBSC
, o-chlorobenzenesulfochloride
, orthochlorobenzol sulfochloride
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Sulfones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Synthesis and antiinflammatory activity of 4-aminoantipyrine derivatives of succinamides
D. Burdulene
,
A. Palaima
,
Z. Stumbryavichyute
,
Z. Talaikite
Pharmaceutical Chemistry Journal
1999
Corpus ID: 38574252
Substituted 4-(N-antipyryl)succinediamides I I I V were obtained by aminolysis of [3-carbomethoxypropionamide (I) with ethanol…
Expand
1997
1997
Synthesis and antiviral activity of N[p-(R-sulfamoyl)phenyl]succinamic acids and their salts with 2-amino-2-thiazoline
D. Burdulene
,
Z. Stumbryavichyute
,
Z. Talaikite
,
G. V. Vladyko
,
E. Boreko
,
L. Korobchenko
Pharmaceutical Chemistry Journal
1997
Corpus ID: 33534422
471 The purpose of this work was to search for new antiviral drugs in the series of succinamic acid derivatives (I XIV). The…
Expand
1991
1991
Sulfonylation of phenols with 2-phenylethylene sulfochloride in the presence of triethylamine
N. N. Maksimenko
,
S. V. Raskosova
,
V. Enya
1991
Corpus ID: 100419867
1960
1960
Infrarot‐ und ramanspektroskopische Untersuchungen an homologen und stellungsisomeren n‐Alkanderivaten 2. Mitteilung: Über die Schwingungsspektren der sekundären Sulfochloride des Propans, n‐Butans…
G. Geiseler
,
K. O. Bindernagel
1960
Corpus ID: 177293896
Es werden die Infrarot- und Ramanspektren der sekundaren Sulfochloride des Propans, n-Butans sowie n-Pentans mitgeteilt und die…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE